- Safety and Temporal Pattern of the Lymphocyte Count During Fingolimod Therapy in Patients With Multiple Sclerosis: Real-World Korean Experience
-
Huh SY, Kim SH, Kim KH, Kwon YN, Kim SM, Kim SW, Shin HY, Chung YH, Min JH, So J, Lim YM, Kim KK, Kim NH, Nam TS, Kang SY, Oh J, Oh Si, Sohn E, Kim HJ
- KMID: 2534754
- J Clin Neurol.
- 2022 Nov;18(6):663-670.
- doi: 10.3988/jcn.2022.18.6.663
Background and Purpose Fingolimod (FTY) inhibits lymphocyte egress from lymphoid organs to cause lymphopenia, but the clinical implications of FTY-induced lymphopenia are not fully understood. We aimed to determine the... -
- CITED
-
- Close
- SHARE
-
- Close
- Neuroinflammation after Intracerebral Hemorrhage and Potential Therapeutic Targets
-
Tschoe C, Bushnell C, Duncan PW, Alexander-Miller MA, Wolfe SQ
- KMID: 2500917
- J Stroke.
- 2020 Jan;22(1):29-46.
- doi: 10.5853/jos.2019.02236
Spontaneous intracerebral hemorrhage (ICH) is a catastrophic illness causing significant morbidity and mortality. Despite advances in surgical technique addressing primary brain injury caused by ICH, little progress has been made... -
- CITED
-
- Close
- SHARE
-
- Close
- Sphingosine 1-Phosphate Receptor Modulators and Drug Discovery
-
Park SJ, Im DS
- KMID: 2367621
- Biomol Ther.
- 2017 Jan;25(1):80-90.
- doi: 10.4062/biomolther.2016.160
Initial discovery on sphingosine 1-phosphate (S1P) as an intracellular second messenger was faced unexpectedly with roles of S1P as a first messenger, which subsequently resulted in cloning of its G... -
- CITED
-
- Close
- SHARE
-
- Close
